New patent expiration for Sunovion Pharms drug KYNMOBI
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one […]
New patent expiration for Sunovion Pharms drug KYNMOBI Read Post »
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one […]
New patent expiration for Sunovion Pharms drug KYNMOBI Read Post »
Annual Drug Patent Expirations for ZYKADIA Zykadia is a drug marketed by Novartis and is included in two NDAs. It
Annual Drug Patent Expirations for NOURIANZ Nourianz is a drug marketed by Kyowa Kirin and is included in one NDA.
New patent expiration for Kyowa Kirin drug NOURIANZ Read Post »
JANUMET XR (metformin hydrochloride; sitagliptin phosphate) Merck sharp dohme Patent: 6,699,871 Expiration: Jan 26, 2023 See More … For more
Drug Patent Expirations for the Week of January 22, 2023 Read Post »
Annual Drug Patent Expirations for STEGLUJAN Steglujan is a drug marketed by Msd Sub Merck and is included in one
New patent expiration for Msd Sub drug STEGLUJAN Read Post »
Annual Drug Patent Expirations for JANUMET Janumet is a drug marketed by Merck Sharp Dohme and is included in two
New patent expiration for Merck Sharp drug JANUMET Read Post »
Annual Drug Patent Expirations for JANUVIA Januvia is a drug marketed by Merck Sharp Dohme and is included in one
New patent expiration for Merck Sharp drug JANUVIA Read Post »
Annual Drug Patent Expirations for JUVISYNC Juvisync is a drug marketed by Merck Sharp Dohme and is included in one
New patent expiration for Merck Sharp drug JUVISYNC Read Post »
Annual Drug Patent Expirations for JANUMET+XR Janumet Xr is a drug marketed by Merck Sharp Dohme and is included in
New patent expiration for Merck Sharp drug JANUMET XR Read Post »
Get fresh news and insights, drug patent expirations & more…